Home
Library
Biological Agents
Drugs
Further Tests
Test Group
Further Test
Conditions
Signs & Symptoms
Treatments
Disorder List
Diagnosis
Standard Diagnosis
Disease List
Medication List
Diagnostic Tests
Signs & Symptoms
Contact Us
Fibrinopeptide A (FPA) Action Assay
Reference Ranges
Fibrinopeptide A (FPA)
Adult ( > 16y)
Male
0.35
TO
2.50 mg/mL
Adult ( > 16y)
Female
0.70
TO
3.10 mg/mL
Conditions
Acute Lymphocytic Leukimia
Fibrinopeptide A (FPA) (Increased)
Chronic Leukemia
Fibrinopeptide A (FPA) (Increased)
Disseminated Intravascular Coagulation
Fibrinopeptide A (FPA) (Increased)
Heart Transplantation
Fibrinopeptide A (FPA) (Increased)
Arterial Thromboembolism
Fibrinopeptide A (FPA) (Increased)
Venous Thromboembolism
Fibrinopeptide A (FPA) (Increased)
Cavernous Sinus Thrombosis
Fibrinopeptide A (FPA) (Increased)
Deep Vein Thrombosis
Fibrinopeptide A (FPA) (Increased)
Portal Vein Thrombosis
Fibrinopeptide A (FPA) (Increased)
Renal Vein Thrombosis
Fibrinopeptide A (FPA) (Increased)
Superficial Venous Thrombosis
Fibrinopeptide A (FPA) (Increased)
Melanoma
Fibrinopeptide A (FPA) (Increased)
Metastatic Bone Tumors
Fibrinopeptide A (FPA) (Increased)
Metastatic Breast Cancer
Fibrinopeptide A (FPA) (Increased)
Metastatic Breat Cancer
Fibrinopeptide A (FPA) (Increased)
Metastatic Liver Cancer
Fibrinopeptide A (FPA) (Increased)
Metastatic Renal Cancer
Fibrinopeptide A (FPA) (Increased)
Metastatic Renal Cell Carcinoma
Fibrinopeptide A (FPA) (Increased)
Adrenocortical Carcinoma
Fibrinopeptide A (FPA) (Increased)
Hepatocellular Carcinoma
Fibrinopeptide A (FPA) (Increased)
Oral Squamous Cell Carcinoma
Fibrinopeptide A (FPA) (Increased)
Squamous Cell Carcinoma
Fibrinopeptide A (FPA) (Increased)
Anal Cancer
Fibrinopeptide A (FPA) (Increased)
Anorectal Cancer
Fibrinopeptide A (FPA) (Increased)
Bladder Cancer
Fibrinopeptide A (FPA) (Increased)
Brain Cancer
Fibrinopeptide A (FPA) (Increased)
Breast Cancer
Cervical Cancer
Fibrinopeptide A (FPA) (Increased)
Colon Cancer
Fibrinopeptide A (FPA) (Increased)
Colorectal Cancer
Fibrinopeptide A (FPA) (Increased)
Endometrial Cancer
Fibrinopeptide A (FPA) (Increased)
Esophageal Cancer
Fibrinopeptide A (FPA) (Increased)
Gastric Cancer
Fibrinopeptide A (FPA) (Increased)
Kidney Cancer
Fibrinopeptide A (FPA) (Increased)
Liver Cancer
Fibrinopeptide A (FPA) (Increased)
Lung Cancer
Fibrinopeptide A (FPA) (Increased)
Oesophaegal Cancer
Fibrinopeptide A (FPA) (Increased)
Oral Cavity Cancer
Fibrinopeptide A (FPA) (Increased)
Ovarian Cancer
Fibrinopeptide A (FPA) (Increased)
Pancreatic Cancer
Fibrinopeptide A (FPA) (Increased)
Papillary Cancer
Fibrinopeptide A (FPA) (Increased)
Pharyngeal Cancer
Fibrinopeptide A (FPA) (Increased)
Primary Liver Cancer
Fibrinopeptide A (FPA) (Increased)
Prostate Cancer
Fibrinopeptide A (FPA) (Increased)
Renal Cell Cancer
Fibrinopeptide A (FPA) (Increased)
Stomach Cancer
Fibrinopeptide A (FPA) (Increased)
Thyroid Cancer
Fibrinopeptide A (FPA) (Increased)
Undifferentiated Thyroid Cancer
Inflammatory Bowel Disease
Fibrinopeptide A (FPA) (Increased)
Inflammatory Vaginitis
Fibrinopeptide A (FPA) (Increased)
Pelvic Inflammatory Disease
Fibrinopeptide A (FPA) (Increased)
Postoperative Pain
Fibrinopeptide A (FPA) (Increased)
Bladder Trauma
Fibrinopeptide A (FPA) (Increased)
Eyeball Trauma
Fibrinopeptide A (FPA) (Increased)
Renal Trauma
Fibrinopeptide A (FPA) (Increased)
Traumatic Hemolytic Anemia
Fibrinopeptide A (FPA) (Increased)
Ureteral Trauma
Fibrinopeptide A (FPA) (Increased)
Protein C Deficiency
Fibrinopeptide A (FPA) (Increased)
Protein S Deficiency
Fibrinopeptide A (FPA) (Increased)
Antithrombin III Deficiency
Fibrinopeptide A (FPA) (Increased)
Cellulitis
Fibrinopeptide A (FPA) (Increased)
Orbital Cellulitis
Fibrinopeptide A (FPA) (Increased)
Preseptal Cellulitis
Fibrinopeptide A (FPA) (Increased)
Acinetobacter Infections
Fibrinopeptide A (FPA) (Increased)
Anaerobic Bacteria Infection
Fibrinopeptide A (FPA) (Increased)
Bacterial Urinary Tract Infections
Fibrinopeptide A (FPA) (Increased)
Campylobacter Infections
Fibrinopeptide A (FPA) (Increased)
Chlamydial Infection
Fibrinopeptide A (FPA) (Increased)
Clostridial Intra Abdominal Infections
Fibrinopeptide A (FPA) (Increased)
Clostridial Soft Tissue Infections
Fibrinopeptide A (FPA) (Increased)
Congenital Cytomegalovirus Infection
Fibrinopeptide A (FPA) (Increased)
Cytomegalovirus Infection
Fibrinopeptide A (FPA) (Increased)
E coli Infection
Fibrinopeptide A (FPA) (Increased)
E Coli O157 H7 Infection
Fibrinopeptide A (FPA) (Increased)
Ebola Virus Infections
Fibrinopeptide A (FPA) (Increased)
Enterococcal Infection
Fibrinopeptide A (FPA) (Increased)
Fungal Urinary Tract Infections
Fibrinopeptide A (FPA) (Increased)
Gonococcal Infection
Fibrinopeptide A (FPA) (Increased)
HACEK Infections
Haemophilus Infection
Fibrinopeptide A (FPA) (Increased)
Hantavirus Infection
Fibrinopeptide A (FPA) (Increased)
Helicobacter Pylori Infection
Fibrinopeptide A (FPA) (Increased)
Hepatitis B Infection
Fibrinopeptide A (FPA) (Increased)
Hepatitis C Infection
Fibrinopeptide A (FPA) (Increased)
Hepatitis D Infection
Fibrinopeptide A (FPA) (Increased)
Hepatitis E Infection
Fibrinopeptide A (FPA) (Increased)
Herpes Simplex Virus Infections
Fibrinopeptide A (FPA) (Increased)
Hookworm Infection
Fibrinopeptide A (FPA) (Increased)
Human Immunodeficiency Virus Infection in Children
Fibrinopeptide A (FPA) (Increased)
Human Metapneumovirus Infections
Fibrinopeptide A (FPA) (Increased)
Hymenolepis Diminuta Infection
Fibrinopeptide A (FPA) (Increased)
Hymenolepis Nana Infection
Fibrinopeptide A (FPA) (Increased)
Klebsiella Infections
Fibrinopeptide A (FPA) (Increased)
Legionella Infections
Fibrinopeptide A (FPA) (Increased)
Lower Respiratory Tract Infection
Fibrinopeptide A (FPA) (Increased)
Lower Urinary Tract Infection
Fibrinopeptide A (FPA) (Increased)
Marburg Infections
Fibrinopeptide A (FPA) (Increased)
Moraxella Catarrhalis Infection
Fibrinopeptide A (FPA) (Increased)
Mycoplasmal Infection
Fibrinopeptide A (FPA) (Increased)
Necrotizing Subcutaneous Infection
Fibrinopeptide A (FPA) (Increased)
Neonatal Hepatitis B Virus Infection
Fibrinopeptide A (FPA) (Increased)
Neonatal Herpes Simplex Virus Infection
Fibrinopeptide A (FPA) (Increased)
Noncholera Vibrio Infections
Fibrinopeptide A (FPA) (Increased)
Parainfluenza Virus Infections
Fibrinopeptide A (FPA) (Increased)
Pigmented Fungi Infection
Fibrinopeptide A (FPA) (Increased)
Proteeae Infections
Fibrinopeptide A (FPA) (Increased)
Respiratory Chest Infection
Fibrinopeptide A (FPA) (Increased)
Respiratory Syncytial Virus Infection
Fibrinopeptide A (FPA) (Increased)
Respiratory Tract Infection
Fibrinopeptide A (FPA) (Increased)
Salivary Gland Infections
Fibrinopeptide A (FPA) (Increased)
Sexually Transmitted Enteric Infections
Fibrinopeptide A (FPA) (Increased)
Staphylococcal Infection
Fibrinopeptide A (FPA) (Increased)
Streptococcal Infection
Fibrinopeptide A (FPA) (Increased)
Submandibular Space Infection
Fibrinopeptide A (FPA) (Increased)
Taeniasis Saginata Infection
Fibrinopeptide A (FPA) (Increased)
Taeniasis Solium Infection
Fibrinopeptide A (FPA) (Increased)
Tooth Infection
Fibrinopeptide A (FPA) (Increased)
Trematode Infections
Fibrinopeptide A (FPA) (Increased)
Upper Respiratory Chest Infection
Fibrinopeptide A (FPA) (Increased)
Upper Urinary Tract Infection
Fibrinopeptide A (FPA) (Increased)
Ureaplasmal Infection
Fibrinopeptide A (FPA) (Increased)
Urinary Tract Infection (Cystitis)
Fibrinopeptide A (FPA) (Increased)
AIDS
Fibrinopeptide A (FPA) (Increased)
Human Immunodeficiency Virus (HIV AIDS)
Fibrinopeptide A (FPA) (Increased)
Extrapulmonary Tuberculosis
Fibrinopeptide A (FPA) (Increased)
Perinatal Tuberculosis
Fibrinopeptide A (FPA) (Increased)
Tuberculosis
Fibrinopeptide A (FPA) (Increased)
Myocardial Infarction
Fibrinopeptide A (FPA) (Increased)
Spinal Cord Infarction
Fibrinopeptide A (FPA) (Increased)
Pulmonary Embolism
Fibrinopeptide A (FPA) (Increased)
Systemic Lupus Erythematosus
Fibrinopeptide A (FPA) (Increased)
Lupus Nephritis
Fibrinopeptide A (FPA) (Increased)
GT:4.457